Dr Chiplin is Managing Director of Newstar Ventures Ltd and has significant operational, investment and transactions experience in the international life science and technology industries. Between 1995 and 2014, Dr Chiplin served as CEO at three leading publicly-listed software, biotechnology and cancer immunotherapy companies. Based in London, UK, Dr Chiplin currently serves on the boards of Batu Biologics, Scancell Holdings plc (LSE: SCLP, Chairman) and ScienceMedia. He is current director of Adalta Ltd and former director of Cynata Therapeutics Ltd. He is member of the Risk committee.
John Chiplin
Follow
Get notifications in MyBN when activity occurs.
Person Activity
![]() |
NEW ROLE: Non-Executive Director, Regeneus | 03 Nov 2020 |